中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A structurally defined galactoglucan from Arisaema erubescens with a multi-target tumor-associated protein binding domain

文献类型:期刊论文

作者Zhu, Yue1,2,3,4; Jin, Can2; Ding, Kan1,2,3,4
刊名CARBOHYDRATE RESEARCH
出版日期2026-02-01
卷号560页码:12
关键词Polysaccharide structure Multi-target binding Antitumor potential alpha-Glucosidase resistance Arisaema erubescens (Wall.) Schott
ISSN号0008-6215
DOI10.1016/j.carres.2025.109781
通讯作者Jin, Can(jincan@zidd.ac.cn) ; Ding, Kan(dingkan@simm.ac.cn)
英文摘要As targeted therapy assumes an increasingly pivotal role in comprehensive cancer treatment, there is a growing imperative to develop natural drugs that exhibit low toxicity and minimal side effects. Polysaccharides derived from the traditional Chinese herbal medicine Arisaema erubescens have been reported to show antitumor potential, however the key structural features and specific molecular targets responsible for their pharmacological effects are still vague. To address this question, a homogeneous polysaccharide TNX05 (Mw approximate to 9 kDa) was obtained and characterized from Arisaema erubescens. Structural analysis suggested that TNX05 was a galactoglucan with a backbone of 1, 4-alpha-D-Glcp, 1, 4-(3-D-Glcp, and 1, 3-(3-D-Galp residues, with side chains--*1-alpha/(3-D-Glcp-(6-* 1)-alpha-D-Glcp and-*1)-alpha-D-Glcp-substituted at the C-4 and C-6 of the 1, 4-alpha-D-Glcp units, respectively. Combining enzymatic hydrolysis, molecular docking, and protein-binding assays we showed a key core domain (TNX05II), which exhibited micromolar-range binding affinity for ten tumor-associated targets: Glypican-6 (GPC-6), glucuronic acid epimerase (Glce), S100 calcium-binding protein A4 (S100A4), S100A6, nucleoside diphosphate kinase 1 (NME1), fibroblast growth factor 17 (FGF17), proto-oncogene tyrosine-protein kinase Src (SRC), kelch-like ECH-associated protein 1 (KEAP1), Galectin-3 (Gal-3), and protein phosphatase 3 catalytic subunit alpha (PPP3CA). Additionally, TNX05II was significantly resistant to alpha-glucosidase degradation. This study suggests a possible key structure-target relationship underlying TNX05's antitumor activity, providing a molecular basis for the antitumor mechanism of Arisaema polysaccharides.
WOS关键词POLYSACCHARIDES ; GLUCANS
资助项目Shanghai Post-doctoral Excellence Program[2022686] ; Zhongshan Active structural domains, targeting, functional mechanisms of polysaccharides and their creation of new anti-tumor drugs Project[CXTD2022012]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
语种英语
WOS记录号WOS:001636463900001
出版者ELSEVIER SCI LTD
源URL[http://119.78.100.183/handle/2S10ELR8/322375]  
专题中国科学院上海药物研究所
通讯作者Jin, Can; Ding, Kan
作者单位1.Henan Univ Chinese Med, Acad Chinese Med Sci, Zhengzhou 450046, Peoples R China
2.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, SSIP Healthcare & Med Demonstrat Zone, Zhongshan 528400, Guangdong, Peoples R China
3.Henan Key Lab Chinese Med Polysaccharides & Drugs, Zhengzhou 450046, Peoples R China
4.Henan Polysaccharide Res Ctr, Zhengzhou 450046, Peoples R China
推荐引用方式
GB/T 7714
Zhu, Yue,Jin, Can,Ding, Kan. A structurally defined galactoglucan from Arisaema erubescens with a multi-target tumor-associated protein binding domain[J]. CARBOHYDRATE RESEARCH,2026,560:12.
APA Zhu, Yue,Jin, Can,&Ding, Kan.(2026).A structurally defined galactoglucan from Arisaema erubescens with a multi-target tumor-associated protein binding domain.CARBOHYDRATE RESEARCH,560,12.
MLA Zhu, Yue,et al."A structurally defined galactoglucan from Arisaema erubescens with a multi-target tumor-associated protein binding domain".CARBOHYDRATE RESEARCH 560(2026):12.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。